Schuster D P, Crouch E C, Parks W C, Johnson T, Botney M D
Department of Internal Medicine, Washington University Medical School, Jewish Hospital of St. Louis, Missouri, USA.
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1087-91. doi: 10.1164/ajrccm.154.4.8887612.
We compared immunoreactivity for angiotensin converting enzyme (ACE) in pulmonary artery and lung parenchymal tissues (obtained at the time of resection for lung transplantation) from eight patients with Stage IV primary pulmonary hypertension (PPH) with the reactivity in similar tissues from eight normal donors. ACE immunoreactivity was markedly and consistently increased in the endothelium and subendothelial neointimal regions of elastic pulmonary arteries from patients with PPH as compared with normal pulmonary arteries. Immunoreactivity in normal muscular pulmonary arteries was usually less than in surrounding capillary endothelial cells, whereas it was usually of comparable intensity with that in surrounding alveolar capillaries in muscular pulmonary arteries of patients with PPH. These observations suggest that ACE may be involved in the pathogenesis of vascular remodeling associated with neointimal formation in pulmonary arteries.
我们比较了8例IV期原发性肺动脉高压(PPH)患者肺移植切除时获取的肺动脉和肺实质组织中血管紧张素转换酶(ACE)的免疫反应性,以及8例正常供体相似组织中的反应性。与正常肺动脉相比,PPH患者弹性肺动脉内皮和内皮下新生内膜区域的ACE免疫反应性显著且持续增加。正常肌性肺动脉中的免疫反应性通常低于周围毛细血管内皮细胞,而在PPH患者的肌性肺动脉中,其免疫反应性通常与周围肺泡毛细血管中的强度相当。这些观察结果表明,ACE可能参与了与肺动脉新生内膜形成相关的血管重塑的发病机制。